Potent pro-apoptotic activity has been observed for exogenous GAS5 lncRNA constructs in cells which exhibit marked reductions in endogenous GAS5 expression, including for example triple-negative breast cancer and hormone-resistant prostate cancer cells [48,49], indicating that such cells retain GAS5 sensitivity. The gene discussed is GAS5; the disease is triple-negative breast carcinoma.